Potential of insulin nanoparticle formulations for oral delivery and diabetes treatment
MetadataShow full item record
© 2017 Elsevier B.V. Nanoparticles have demonstrated significant advancements in potential oral delivery of insulin. In this publication, we review the current status of polymeric, inorganic and solid-lipid nanoparticles designed for oral administration of insulin. Firstly, the structure and physiological function of insulin are examined. Then, the efficiency and shortcomings of insulin nanoparticle are discussed. These include the susceptibility to digestive enzyme degradation, instability in the acidic pH environment, poor mucus diffusion and inadequate permeation through the gastrointestinal epithelium. In order to optimise the nanocarriers, the following considerations, including polymer nature, surface charge, size, polydispersity index and morphology of nanoparticles, have to be taken into account. Some novel designs such as chitosan-based glucose-responsive nanoparticles, layer by layer technique-based nanoparticles and zwitterion nanoparticles are being adopted to overcome the physiological challenges. The review ends with some future directions and challenges to be addressed for the success of oral delivery of insulin-loaded nanoparticle formulation.
Showing items related by title, author, creator and subject.
Gedawy, A.; Martinez, Jorge; Al-Salami, Hani; Dass, Crispin (2017)Objectives: The chronic and progressive nature of diabetes is usually associated with micro- and macrovascular complications where failure of pancreatic ß-cell function and a general condition of hyperglycaemia is created. ...
Microparticles, microcapsules and microspheres: A review of recent developments and prospects for oral delivery of insulinWong, C.; Al-Salami, Hani; Dass, Crispin (2018)© 2017 Elsevier B.V. Diabetes mellitus is a chronic metabolic health disease affecting the homeostasis of blood sugar levels. However, subcutaneous injection of insulin can lead to patient non-compliance, discomfort, pain ...
Wong, Chun Yuen Jerry (2020)Diabetes mellitus is a chronic metabolic disorder. To improve patient compliance and alleviate the unwanted side effects that are associated with insulin injections, the project aimed to evaluate the potential of nanoparticles ...